 HANOVER, MD., May 18, 2021 GLOBE NEWSWIRE -- Processa Pharmaceuticals, Inc. NASDAQ: PCSA, Processa or the Company, a clinical-stage biopharmaceutical company developing products to improve the survival andor quality of life for patients who have unmet medical needs, today announced today that management will participate in two upcoming investor conferences: 